ASO Test

Introduction

  1. The Anti-Streptolysin O (ASO) test is a vital diagnostic tool for measuring antibodies produced against Streptolysin O (SLO), a cytotoxic enzyme secreted by Streptococcus pyogenes.
  2. These antibodies indicate exposure to or infection by Group A Streptococcus.
  3. Elevated ASO titers are associated with post-streptococcal complications such as:
  • Rheumatic fever (affecting the heart, joints, and nervous system).
  • Post-streptococcal glomerulonephritis (inflammation of the kidneys).

Key Points:

  • ASO titers begin to rise 1–3 weeks post-infection, peak around 3–6 weeks, and decline over months.
  • ASO levels are expressed in Todd units (International Units, IU/mL).

Principle

The ASO test relies on the ability of anti-SLO antibodies in the patient’s serum to neutralize the hemolytic activity of the SLO enzyme:

  1. Neutralization of Hemolysis:
    • SLO can lyse red blood cells (RBCs).
    • When a serum containing anti-SLO antibodies is mixed with SLO, the antibodies neutralize the enzyme, preventing RBC lysis.
  2. Qualitative Test: Determines the presence of anti-SLO antibodies.
  3. Quantitative Test: Determines the highest serum dilution (titer) that inhibits hemolysis completely.

Requirements

  1. Sample
    • Collect venous blood in a plain (clot) tube.
    • Allow clotting at room temperature and centrifuge at 2,500–3,000 rpm for 10 minutes to separate serum.
    • Avoid hemolysis or contamination.
    • Use fresh serum or store at 2–8°C (up to 7 days). For longer storage, freeze at −20°C.
  1. Reagents
    1. Streptolysin O (SLO):
      • A lyophilized preparation reconstituted per manufacturer instructions.
      • Concentration must be standardized (e.g., causing complete hemolysis of a defined RBC volume).
    2. Sensitized RBCs:
      • Sheep red blood cells (1%–2%) washed and suspended in isotonic saline.
    3. Diluent:
      • Normal saline or phosphate-buffered saline (PBS).
    4. Controls:
      • Positive Control: Serum with known anti-SLO concentration.
      • Negative Control: Normal saline or serum without ASO antibodies.
  1. Equipment
    • Test tubes or microtiter plates for serial dilution.
    • Micropipettes and disposable tips.
    • The incubator or water bath is maintained at 37°C.
    • Timer or stopwatch.

Procedure

Qualitative ASO Test (Screening)

The qualitative ASO test is a rapid screening method used to detect the presence of Antistreptolysin O (ASO) antibodies in serum by observing visible agglutination.

Materials Required

  • Patient serum sample
  • ASO latex reagent
  • Positive control
  • Negative control
  • Reaction slide (glass or disposable)
  • Disposable mixing sticks
  • Mechanical rotator (optional)

Procedure

Step 1: Prepare the Reagents

  • Bring the serum sample and ASO latex reagent to room temperature (20–30°C).
  • Mix the latex reagent gently before use. Do not shake vigorously.

Step 2: Label the Reaction Circle

  • Label separate circles on the reaction slide for the patient sample, positive control, and negative control.

Step 3: Add the Serum Sample

  • Place 50 µL (one drop) of the patient’s serum into the designated reaction circle.

Step 4: Add the Latex Reagent

  • Add one drop of ASO latex reagent to the serum sample.

Step 5: Mix the Reagents

  • Using a clean disposable applicator stick, mix the serum and reagent evenly over the entire reaction circle.

Step 6: Rotate the Slide

  • Gently rotate the slide manually or place it on a mechanical rotator at approximately 80–100 rpm for 2 minutes.

Step 7: Observe the Reaction

  • Examine the reaction immediately under adequate lighting for visible agglutination.

Interpretation of Results

Observation Result Interpretation
Visible agglutination Positive ASO antibodies are present (≥ kit detection limit, commonly 200 IU/mL).
No agglutination Negative ASO antibodi

es are absent or below the detection limit.


Quantitative ASO Test (Titration)

Materials Required

  • Patient serum (qualitative ASO positive)
  • ASO latex reagent
  • Isotonic saline (0.9% NaCl)
  • Reaction slide with multiple circles
  • Micropipette or disposable droppers
  • Mixing sticks
  • Mechanical rotator (optional)

Procedure

Step 1: Prepare Serial Dilutions

  • Label six reaction circles or tubes as 1:2, 1:4, 1:8, 1:16, 1:32, and 1:64.
  • Prepare serial two-fold dilutions of the patient’s serum using normal saline.

Step 2: Add Diluted Serum

  • Place 50 µL (one drop) of each diluted serum sample into the corresponding reaction circle.

Step 3: Add ASO Latex Reagent

  • Add one drop of ASO latex reagent to each diluted serum sample.

Step 4: Mix the Reagents

  • Mix each reaction thoroughly using a separate disposable mixing stick.

Step 5: Rotate the Slide

  • Rotate the slide manually or on a mechanical rotator at 80–100 rpm for 2 minutes.

Step 6: Observe for Agglutination

  • Examine each dilution for visible agglutination under good lighting.

Step 7: Determine the End-Point Titer

  • The highest serum dilution showing visible aggl

    utination is considered the ASO antibody titer.


Calculation of ASO Titer

The ASO concentration is calculated using the formula:

ASO Titer (IU/mL) = Sensitivity of the reagent × Highe

st positive dilution

Example:

  • Kit sensitivity = 200 IU/mL
  • Highest positive dilution = 1:8

ASO Titer = 200 × 8 = 1600 IU/mL


Interpretation of Results

 

Highest Positive Dilution ASO Titer (IU/mL)*
Undiluted (1:1) 200
1:2 400
1:4 800
1:8 1600
1:16 3200
1:32 6400
1:64 12,800

Results

Normal ASO Ranges

    • Adults: Up to 200 IU/mL.
    • Children (5–12 years): Up to 250 IU/mL.

Significant Titers

    • A single elevated ASO titer is not conclusive of active disease. Instead:
      • Rising Titers: A fourfold increase in ASO titer over 2–3 weeks is significant.

Reporting

    • Results are expressed in Todd units or IU/mL.
      • 1 Todd unit = the amount of antibody that neutralizes 0.01 mL of SLO.

Clinical Significance

1. Diagnosis of Rheumatic Fever

  • Elevated ASO levels support the diagnosis of acute rheumatic fever in patients with a history of recent streptococcal throat infection.

2. Diagnosis of Post-Streptococcal Glomerulonephritis (PSGN)

  • Helps confirm a recent streptococcal infection in patients presenting with hematuria, edema, and hypertension.

3. Evidence of Recent Streptococcal Infection

  • Indicates a recent infection with Group A Streptococcus, especially when throat culture is negative or antibiotics have already been started.

4. Monitoring Antibody Response

  • Serial ASO titers can help assess the rise or fall of antibody levels, indicating recent infection or recovery.

5. Differentiating Post-Infectious Complications

  • Helps distinguish complications caused by a previous streptococcal infection from those due to other diseases.

6. Supportive Diagnostic Test

  • The ASO test should be interpreted along with clinical findings and other laboratory tests such as Anti-DNase B, CRP, ESR, and throat culture for accurate diagnosis.

7. Guiding Patient Management

  • Early identification of post-streptococcal complications allows timely treatment and helps prevent long-term complications, particularly rheumatic heart disease.

Limitations

  1. False Negatives:
    • Not all streptococcal infections produce significant ASO levels (e.g., skin infections like impetigo).
  2. False Positives:
    • Elevated ASO titers may persist after the resolution of infection.
  3. Non-Specificity:
    • ASO cannot distinguish between recent and remote infections.
    • Results must be interpreted alongside clinical findings and other investigations.

Precautions

  1. Reagents and Controls:
    • Always use fresh or properly stored reagents. Validate test accuracy with controls.
  2. Temperature Control:
    • Maintain consistent incubation temperatures (37°C) for reliable results.
  3. Interpretation:
    • Always interpret ASO titers in the clinical context; elevated titers alone are not diagnostic of disease.
Scroll to Top
Enable Notifications OK No thanks